Xiamen Amoytop Biotech Co., Ltd. Class ASSE: 688278

Announcement on the Completion of Asset Transfer by Wholly-Owned Subsidiary in the Acquisition of Partial Assets of Skyline Therapeutics Limited

· Issued by Xiamen Amoytop Biotech Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Completion of Asset Transfer by Wholly-Owned Subsidiary in the Acquisition of Partial Assets of Skyline Therapeutics Limited

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis